Exclusive

Publication

Byline

Shimadzu invests in OptQC to advance next-generation R&D infrastructure for drug discovery

Singapore, Aug. 26 -- Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from The University of Tokyo, through its Corporate Venture Capital (CVC) fund, "Shimadzu Futur... Read More


Korea's SK Biopharmaceuticals partners with Biohaven for epilepsy treatment

Singapore, Aug. 26 -- US-based Biohaven and SK Biopharmaceuticals, based in South Korea, have announced a strategic global licensing and collaboration agreement under which SK Biopharmaceuticals will ... Read More


Korea's Hanmi Pharm signs $2.3 B deal with Genentech for novel obesity therapy

Singapore, Aug. 25 -- South Korea-based Hanmi Pharm has entered into an exclusive licensing agreement with Genentech, a member of the Roche Group, for the development, manufacturing, and commercialisa... Read More


Australia builds lung cancer research truck to transport early detection technology

Singapore, Aug. 25 -- A mobile clinic has been launched as part of an initiative of The University of Queensland (UQ) and the Australian Cancer Research Foundation (ACRF) that aims to trial state-of-t... Read More


Japan's SkyDrive inks medical logistics partnership with Air India and Suzuki

Singapore, Aug. 25 -- SkyDrive Inc., a leading Japanese developer, manufacturer, and seller of compact eVTOL (electric vertical takeoff and landing) aircraft, has announced that it will move forward w... Read More


WHO and Peking University strengthen collaboration to advance health emergency preparedness

Singapore, Aug. 25 -- The World Health Organization (WHO) and China's Peking University have entered into a two-year project collaboration agreement to strengthen global health emergency preparedness ... Read More


Taiwan's Lotus Pharma inks biosimilars agreement with Alvotech for US and selected Asian markets

Singapore, Aug. 25 -- Taiwan-based Lotus Pharmaceutical Co. has announced a strategic licensing and commercialisation agreement with Alvotech, covering two of Alvotech's candidates in the United State... Read More


GC Biopharma's Hunter Syndrome treatment 'Hunterase' receives drug approval in India and Taiwan

Singapore, Aug. 24 -- GC Biopharma, a leading global pharmaceutical company based in South Korea, has announced that its Hunter syndrome treatment, 'Hunterase IV', has received marketing authorisation... Read More


Hong Kong Applied Science and Technology Research Institute advances AI-enabled biomaterials and digital health innovation

Singapore, Aug. 24 -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU), US have signed a Memorandum of Understanding (MoU) to establish a stra... Read More


Korea's Rznomics joins Lilly Gateway Labs in US to accelerate RNA Therapeutics

Singapore, Aug. 24 -- South Korea based Rznomics Inc, a biopharmaceutical company specialising in the development of RNA-based gene therapies, has announced that it is joining Lilly Gateway Labs (LGL)... Read More